Episode Details
Back to Episodes
258: Pharma vs. PBMs, Sarepta at the FDA, & a bold idea gone awry
Published 3 years, 5 months ago
Description
We discuss a Senate hearing that put major pharma CEOs in the same room with the middlemen they love to blame for rising drug prices, with mixed results. We also explain what is a massive week for Sarepta Therapeutics, the FDA, and the future of gene therapies for rare diseases, plus the latest news in the life sciences.